Palforzia
Indication
Palforzia for treating peanut allergy in children and young people (NICE TA769)
NICE TA769 - Palforzia for treating peanut allergy in children and young people
Red
Brand:
Nice TA:
769
Commissioning responsibility:
PbR excluded:
No
BNF chapter:
Respiratory system
Background
1.1 Palforzia is recommended, within its marketing authorisation, as an option for treating peanut allergy in children aged 4 to 17. It can be continued in people who turn 18 while on treatment. Palforzia should be used with a peanut-avoidant diet.